Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Slides:

Advertisements

Similar presentations

Randomized controlled trial of remote endarterectomy versus endovascular intervention for TransAtlantic Inter-Society Consensus II D femoropopliteal lesions

Advertisements

Endovascular therapy for acute limb ischemia

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Freedom from secondary interventions to treat stenotic disease after percutaneous transluminal angioplasty of infrarenal aorta: long-term results J.P.P.M.

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

Stenting of femoropopliteal lesions using interwoven nitinol stents

Endovascular treatment of long lesions of the superficial femoral artery: Results from a multicenter registry of a spiral, covered polytetrafluoroethylene.

Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions Wei Ye, MD, Chang-Wei Liu,

Linda Le, MD, William Terral, MD, Nicolas Zea, MD, Hernan A

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Surgical or endovascular revascularization in patients with critical limb ischemia: Influence of diabetes mellitus on clinical outcome Florian Dick,

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

The impact of gender on outcome after infrainguinal arterial reconstructions for peripheral occlusive disease Enzo Ballotta, MD, Mario Gruppo, MD, Renata.

Endovascular management of iliac artery occlusions: extending treatment to TransAtlantic Inter-Society Consensus class C and D patients Christopher D.

Outcomes of polytetrafluoroethylene-covered stent versus bare-metal stent in the primary treatment of severe iliac artery obstructive lesions Michele.

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: Do the results justify an attempt before bypass grafting? Richard.

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Percutaneous transluminal angioplasty versus primary stenting in infrapopliteal arterial disease: A meta-analysis of randomized trials Ridong Wu, MD,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Cryopreserved saphenous vein graft in infrainguinal bypass

Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men Brian.

Amy N. Roach, BS, Sebastian Larion, MS, Sadaf S. Ahanchi, MD, Chad P

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Results of PREVENT III: A multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery Michael.

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Outcomes of reinterventions after subintimal angioplasty

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Syed N. Haider, Eamon G. Kavanagh, MD, Martin Forlee, FCS (SA), Mary P

Grant G. Altobelli, Toshifumi Kudo, MD, PhD, Bradley T. Haas, Fiona A

Number of infrapopliteal arteries undergoing endovascular treatment is not associated with the limb salvage rate in patients with critical limb ischemia

Lower extremity arterial reconstruction for critical limb ischemia in diabetes Enzo Ballotta, MD, Antonio Toniato, MD, Giacomo Piatto, MD, Franco Mazzalai,

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure Vincent J. Santo, MD, Phong.

Current efficacy of open and endovascular interventions for advanced superficial femoral artery occlusive disease Christopher J. Smolock, MD, Javier.

Marc L. Schermerhorn, MD, Kristina A. Giles, MD, Allen D

Pedal bypass surgery after crural endovascular intervention

Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia

Long-term postplacement cost after endovascular aneurysm repair

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia Kevin E. Todd, BS, Sadaf S. Ahanchi, MD, Christian.

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Ilia Gur, MD, William Lee, MD, Gabriel Akopian, MD, Vincent L

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results Jean-Paul P.M. de Vries,

Plaque excision with the Silverhawk catheter: Early results in patients with claudication or critical limb ischemia W. Brent Keeling, MD, Murray L. Shames,

Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease Hasan H.

Rabih A. Chaer, MD, Joel E. Barbato, MD, Stephanie C

Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage Andrea E. Yancey, MD, David J. Minion,

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

Reconstructive surgery for complex aortoiliac occlusive disease in young adults Enzo Ballotta, MD, Renata Lorenzetti, MD, Giacomo Piatto, MD, Francesca.

Donald T. Baril, MD, Luke K. Marone, MD, Justine Kim, Michael R

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

A comparison of the standard bolia technique versus subintimal recanalization plus Viabahn stent graft in the management of femoro-popliteal occlusions

Infrapopliteal angioplasty for critical limb ischemia: Relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs Kristina A. Giles,

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Results of second-time angioplasty and stenting for femoropopliteal occlusive disease and factors affecting outcomes William P. Robinson, MD, Louis L.

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Early and long-term results of percutaneous transluminal angioplasty of the lower abdominal aorta Stéphane Elkouri, MD, Gilles Hudon, MD, Philippe Demers,

Iliac artery stenting versus surgical reconstruction for TASC (transatlantic inter-society consensus) type B and type C iliac lesions Carlos H Timaran,

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

Long-term outcomes and predictors of iliac angioplasty with selective stenting Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD Journal of Vascular Surgery Volume 42, Issue 3, Pages 466.e1-466.e13 (September 2005) DOI: 10.1016/j.jvs.2005.05.002 Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 1 Primary and subsequent endovascular procedures for iliac lesions in 151 limbs. PTA, Percutaneous transluminal angioplasty. Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 2 Cumulative primary, assisted primary, and secondary patency rates after iliac angioplasty with selective stenting in 151 limbs (Kaplan-Meier life table analysis). Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 3 Cumulative continued clinical improvement and limb salvage rates after iliac angioplasty with selective stenting in 151 limbs (Kaplan-Meier life table analysis). The dashed line represents a portion of plot where the standard error (S.E.) is >10%. Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 4 Cumulative primary patency rates of the percutaneous transluminal angioplasty (PTA) group and the stent group. There was no significant difference between the two groups (Kaplan-Meier, log-rank test, P = .66). The dashed line represents a portion of plot where the standard error (S.E.) is >10%. Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 5 Cumulative continued clinical improvement rates of the percutaneous transluminal angioplasty (PTA) group and the stent group. There was no significant difference between the two groups (Kaplan-Meier, log-rank test, P = .71). The dashed line represents a portion of plot where the standard error (S.E.) is >10%. Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions

Fig 6 Primary and subsequent endovascular procedures for TransAtlantic Inter-Society Consensus type B and type C iliac lesions in 107 limbs. PTA, Percutaneous transluminal angioplasty. Journal of Vascular Surgery 2005 42, 466.e1-466.e13DOI: (10.1016/j.jvs.2005.05.002) Copyright © 2005 The Society for Vascular Surgery Terms and Conditions